KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.95

Efficacy of ready-to-use therapeutic food in malnourished children with cancer: Results of a randomized, open-label phase 3 trial.

Maya Prasad, Sneha Tandon, Rajul Gala, Sadhna Kannan, Girish Chinnaswamy, Gaurav Narula, Tushar Vora, Shripad Banavali, Shaesta Mehta, Amey Paradkar, Savita Goswami, Meera Ghadge, Deepak Jagiasi, Sujata Sharma, Lavina Fernandes, Mamta Manglani, Alka Jadhav, Ronald Barr, Elena Ladas

Pediatr Blood Cancer 68(9) e29197

PMID34212474
PMCID-
DOI10.1002/pbc.29197
发表日期2021-07-02
入排依据:The study is a randomized Phase III trial in pediatric cancer with original results, but it evaluates a nutritional intervention (RUTF), not a drug, and its primary/secondary outcomes are not time-to-event efficacy endpoints (e.g., OS, PFS, DFS, EFS, RFS, TTP, or Kaplan-Meier/HR analyses).
摘要

摘要

BACKGROUND: The adverse influence of undernutrition in children with cancer may be remediated by early nutritional intervention. This study assessed the efficacy of ready-to-use therapeutic food (RUTF) in improving nutritional status and reducing treatment-related toxicities (TRTs) in such children. METHODS: In a randomized controlled phase-3 open-label trial, severely and moderately undernourished children with cancer were randomized 1:1 to receive standard nutritional therapy (SNT) or SNT+RUTF for 6 weeks. The primary outcome (weight gain >10%) and secondary outcomes (improved/maintained nutritional status, improved body composition) were assessed after 6 weeks. TRTs were assessed over 6 months. RESULTS: Between July 2015 and March 2018, 260 subjects were enrolled, 126 were analyzable in both arms at 6 weeks. More children on RUTF had weight gain (98 [77.8%] vs. 81 [64.2%], p = .025) with a greater increase in fat mass as a percentage of body mass (median 2% [IQR -0.12 to 4.9] vs. 0.5% [IQR -1.45 to 2.27, p = .005]) but a greater loss of lean mass (median -1.86% [IQR -4.4 to 0.50] vs. -0.4% [IQR -2.4 to 1.4, p = .007]) compared to the SNT arm. Fewer subjects on the RUTF arm had episodes of severe infection (10.6% vs. 31%, p < .0001), treatment delays (17.7% vs. 39%, p < .0001), and severe mucositis (11% vs. 23.8%, p = .006) compared to the SNT arm. The odds of developing TRTs on the RUTF arm were lower even after adjusting for improvement in nutritional status. CONCLUSIONS: RUTF is efficacious in improving weight gain and nutritional status in undernourished children with cancer and decreases TRTs. Incorporating RUTF into a healthy, balanced diet should be considered in undernourished children with cancer.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。